Dymon Asia Capital (Singapore)’s Tango Therapeutics TNGX Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$313K	Buy	+10,000	New	+$247K	0.01%	216

Other funds holding TNGX

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s TNGX Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 10,000 shares worth $313K. The stake represents 0.01% of the portfolio and ranks #216 among its holdings.

30 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Dymon Asia Capital (Singapore) held 10,000 shares of Tango Therapeutics worth $313K as of Q2 2026.
Tango Therapeutics was a new Dymon Asia Capital (Singapore) position in Q2 2026.
Tango Therapeutics made up 0.01% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #216 holding.
30 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.